Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1
    Austria Belgium Bulgaria Croatia Denmark Estonia +11
  • Study of Bosutinib for Children with Newly Diagnosed or Resistant Chronic Myeloid Leukemia

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    France Germany Italy The Netherlands Spain
  • Study on the Safety and Effectiveness of Rozanolixizumab and Immunoglobulins in Children with Generalized Myasthenia Gravis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Italy Poland
  • Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark France Germany +7
  • Study on Long-Term Spesolimab Treatment for Patients with Generalized Pustular Psoriasis from Previous Trials

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Spain
  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Hungary Italy Poland Romania Spain
  • Study on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Hungary Italy Poland +1
  • Study on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    3 1
    Germany Poland
  • Study on Long-Term Safety of Soticlestat for Patients with Dravet or Lennox-Gastaut Syndromes

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium France Germany Greece Hungary Italy +4
  • Continued Regorafenib Treatment for Patients with Solid Tumors from Previous Bayer Studies

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain